Furthermore, both RUNX3 and RUNX1::ETO expression in HSPC induced a similar downregulation of the transcriptional regulator ID2, which is also downregulated in CBF AML patients [32]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.